HYDROXYUREA VERSUS BUSULFAN IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA

被引：37

作者：

RUSHING, D

GOLDMAN, A

GIBBS, G

HOWE, R

KENNEDY, BJ

机构：

[1] UNIV MINNESOTA, SCH MED, DEPT MED, MED ONCOL SECT, MINNEAPOLIS, MN 55455 USA

[2] UNIV MINNESOTA, SCH MED, DEPT MED, HEMATOL SECT, MINNEAPOLIS, MN 55455 USA

[3] UNIV MINNESOTA, SCH PUBL HLTH, DIV BIOMETRY, MINNEAPOLIS, MN 55455 USA

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1982年 / 5卷 / 03期

关键词：

D O I：

10.1097/00000421-198206000-00013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：307 / 313

页数：7

共 15 条

[1] FISHBEINWN, 1964, CLIN PHARMACOL THER, V5, P574
[2] GALTON DAG, 1969, SEMIN HEMATOL, V6, P323
[3] CYCLIC LEUKOCYTE OSCILLATIONS IN CHRONIC MYELOGENOUS LEUKEMIA DURING HYDROXYUREA THERAPY
KENNEDY, BJ
[J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1970, 35 (06): : 751 - &
[4] SKIN CHANGES SECONDARY TO HYDROXYUREA THERAPY
KENNEDY, BJ
SMITH, LR
GOLTZ, RW
[J]. ARCHIVES OF DERMATOLOGY, 1975, 111 (02) : 183 - 187
[5] METABOLIC AND THERAPEUTIC EFFECTS OF HYDROXYUREA IN CHRONIC MYELOID LEUKEMIA
KENNEDY, BJ
YARBRO, JW
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 195 (12) : 1038 - +
[6] KENNEDY BJ, 1972, CANCER-AM CANCER SOC, V29, P1052, DOI 10.1002/1097-0142(197204)29:4<1052::AID-CNCR2820290454>3.0.CO
[7] 2-7
[8] CHRONIC MYELOGENOUS LEUKEMIA - NEW CONCEPTS .2.
KOEFFLER, HP
GOLDE, DW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (21) : 1269 - 1274
[9] MORLEY AA, 1967, LANCET, V2, P1320
[10] Pensabene A, 1969, Haematol Lat, V12, P767